Ratings Zurich Insurance Group Ltd

Equities

ZURN

CH0011075394

Real-time Estimate Cboe Europe Other stock markets 15:33:24 29/04/2024 BST			5-day change	1st Jan Change
444.4 ^CHF	+1.03%		-1.53%	+1.11%

09:16am	Zurich Insurance Group Logs Lower FY24 Swiss Solvency Test Ratio	MT
04-24	Swisscom Enters Partnerships for New Insurance Products	MT

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

This company will be of major interest to investors in search of a high dividend stock.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company appears highly valued given the size of its balance sheet.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Multiline Insurance & Brokers

	1st Jan change	Capi.	ESG Refinitiv
ZURICH INSURANCE GROUP LTD	+1.11%	69.25B	C+
ALLIANZ SE	+10.02%	110B	B-
CHUBB LIMITED	+9.52%	99.67B	C+
MARSH & MCLENNAN COMPANIES	+4.90%	97.53B	B
TALANX AG	+9.67%	19.64B	A-
BB SEGURIDADE PARTICIPAÇÕES S.A.	-4.70%	12.38B	B-
POWSZECHNY ZAKLAD UBEZPIECZE? SPÓLKA AKCYJNA	+10.26%	10.98B	A-
ASR NEDERLAND N.V.	+9.51%	10.43B	A
ICICI LOMBARD GENERAL INSURANCE COMPANY LIMITED	+20.11%	10B	A-
ASSURANT, INC.	+3.78%	9B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes